# FIND CAN Trial: "CF-172"

> **NCT03033641** · NA · COMPLETED · sponsor: **Biosense Webster, Inc.** · enrollment: 25 (estimated)

## Conditions studied

- Persistent Atrial Fibrillation

## Interventions

- **DEVICE:** Ablation procedure

## Key facts

- **NCT ID:** NCT03033641
- **Lead sponsor:** Biosense Webster, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-05
- **Primary completion:** 2017-05-04
- **Final completion:** 2017-08-30
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2025-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03033641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03033641, "FIND CAN Trial: "CF-172"". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03033641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*